Exosomes-delivered PD-L1 siRNA and CTLA-4 siRNA protect against growth and tumor immune escape in colorectal cancer
Authors:
Open Access
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cellsNature Cell Biology, 2018
- Regulation and Function of the PD-L1 CheckpointImmunity, 2018
- Hsa_circ_0020397 regulates colorectal cancer cell viability, apoptosis and invasion by promoting the expression of the miR‐138 targets TERT and PD‐L1Cell Biology International, 2017
- Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancerNature, 2017
- Exosomes: Nanoparticulate tools for RNA interference and drug deliveryJournal of Cellular Physiology, 2017
- Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal CancerInternational Journal of Molecular Sciences, 2017
- The role of regulatory T cells in cancer immunologyImmunoTargets and Therapy, 2015
- Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T CellsCancer Immunology Research, 2013
- Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in TumorsCancer Research, 2013
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomesNature Biotechnology, 2011